Similar to calprotectin, the role of S100A12 as a biomarker of intestinal inflammation has been better defined in IBD, where faecal S00A12 is shown to be a valid and reliable noninvasive biomarker of intestinal inflammation. This evidence concerns the gene S100A12 and irritable bowel syndrome.